Ideaya Biosciences Inc (NASDAQ: IDYA) is -14.64% lower on its value in year-to-date trading and has touched a low of $23.41 and a high of $47.74 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IDYA stock was last observed hovering at around $31.37 in the last trading session, with the day’s loss setting it -1.0%.
Currently trading at $30.37, the stock is -17.18% and -21.32% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.27 million and changing -3.19% at the moment leaves the stock -23.73% off its SMA200. IDYA registered 11.70% gain for a year compared to 6-month loss of -28.56%. The firm has a 50-day simple moving average (SMA 50) of $38.3551 and a 200-day simple moving average (SMA200) of $39.812374.
The stock witnessed a -23.69% gain in the last 1 month and extending the period to 3 months gives it a -12.93%, and is -12.60% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.72% over the week and 4.64% over the month.
Ideaya Biosciences Inc (IDYA) has around 124 employees, a market worth around $2.57B and $11.96M in sales. Profit margin for the company is -1285.34%. Distance from 52-week low is 29.73% and -36.38% from its 52-week high. The company has generated returns on investments over the last 12 months (-16.48%).
Ideaya Biosciences Inc quarterly earnings per share for the current quarter are estimated at -0.67 with sales reaching $3.75M over the same period.The EPS is expected to shrink by -28.85% this year, but quarterly earnings will post -64.20% year-over-year. Quarterly sales are estimated to shrink -53.30% in year-over-year returns.
293.0 institutions hold shares in Ideaya Biosciences Inc (IDYA), with institutional investors hold 103.18% of the company’s shares. The shares outstanding are 84.48M, and float is at 76.56M with Short Float at 15.29%. Institutions hold 102.08% of the Float.
The top institutional shareholder in the company is FMR LLC with over 11.27 million shares valued at $395.69 million. The investor’s holdings represent 14.4557 of the IDYA Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 6.81 million shares valued at $239.02 million to account for 8.7321 of the shares outstanding. The other top investors are FEDERATED HERMES, INC. which holds 4.86 million shares representing 6.2283 and valued at over $170.49 million, while VANGUARD GROUP INC holds 5.4728 of the shares totaling 4.27 million with a market value of $149.81 million.
Ideaya Biosciences Inc (IDYA) Insider Activity
Ideaya Biosciences Inc disclosed in a document filed with the SEC on May 29 ’24 that WHITE MICHAEL ANTHONY (Chief Scientific Officer) sold a total of 28,500 shares of the company’s common stock. The trade occurred on May 29 ’24 and was made at $36.24 per share for $1.03 million. Following the transaction, the insider now directly holds 0.0 shares of the IDYA stock.
Still, SEC filings show that on May 15 ’24, Hata Yujiro S (President and CEO) disposed off 83,856 shares at an average price of $42.90 for $3.6 million. The insider now directly holds 677,887 shares of Ideaya Biosciences Inc (IDYA).
